Exelixis, Inc. (EXEL)
USD 39.6
(1.83%)
USD 39.6
(1.83%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 189.94 Million USD | -0.12% |
| 2022 | 190.17 Million USD | 270.9% |
| 2021 | 51.27 Million USD | 4.45% |
| 2020 | 49.08 Million USD | 2.24% |
| 2019 | 48.01 Million USD | 294.24% |
| 2018 | 12.17 Million USD | -16.19% |
| 2017 | 14.53 Million USD | 0.0% |
| 2016 | - USD | -100.0% |
| 2015 | 381.43 Million USD | 45.37% |
| 2014 | 262.39 Million USD | -21.78% |
| 2013 | 335.47 Million USD | 4.0% |
| 2012 | 322.56 Million USD | 82.61% |
| 2011 | 176.64 Million USD | 3.48% |
| 2010 | 170.71 Million USD | 322.94% |
| 2009 | 40.36 Million USD | -45.98% |
| 2008 | 74.71 Million USD | -29.34% |
| 2007 | 105.74 Million USD | -2.15% |
| 2006 | 108.07 Million USD | 1.14% |
| 2005 | 106.85 Million USD | -21.71% |
| 2004 | 136.49 Million USD | 34.84% |
| 2003 | 101.22 Million USD | 55.13% |
| 2002 | 65.25 Million USD | 56.12% |
| 2001 | 41.79 Million USD | 424.02% |
| 2000 | 7.97 Million USD | -27.49% |
| 1999 | 11 Million USD | 0.0% |
| 1998 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q3 | 194.44 Million USD | 0.0% |
| 2024 Q1 | 201.46 Million USD | 0.0% |
| 2024 Q2 | 198.01 Million USD | 0.0% |
| 2023 Q3 | 190.85 Million USD | -1.97% |
| 2023 Q4 | 189.94 Million USD | -0.48% |
| 2023 Q2 | 194.69 Million USD | 4.14% |
| 2023 Q1 | 186.94 Million USD | -1.69% |
| 2023 FY | 189.94 Million USD | -0.12% |
| 2022 Q4 | 190.17 Million USD | 18.98% |
| 2022 FY | 190.17 Million USD | 270.9% |
| 2022 Q1 | 50.63 Million USD | -1.24% |
| 2022 Q2 | 161.01 Million USD | 217.99% |
| 2022 Q3 | 159.83 Million USD | -0.73% |
| 2021 Q1 | 52.83 Million USD | 7.64% |
| 2021 Q2 | 53.22 Million USD | 0.73% |
| 2021 FY | 51.27 Million USD | 4.45% |
| 2021 Q4 | 51.27 Million USD | -1.88% |
| 2021 Q3 | 52.25 Million USD | -1.82% |
| 2020 Q3 | 47.62 Million USD | -1.46% |
| 2020 Q4 | 49.08 Million USD | 3.07% |
| 2020 FY | 49.08 Million USD | 2.24% |
| 2020 Q1 | 47.88 Million USD | -0.27% |
| 2020 Q2 | 48.33 Million USD | 0.94% |
| 2019 Q2 | 22.54 Million USD | 12.95% |
| 2019 FY | 48.01 Million USD | 294.24% |
| 2019 Q1 | 19.95 Million USD | 63.89% |
| 2019 Q4 | 48.01 Million USD | 102.54% |
| 2019 Q3 | 23.7 Million USD | 5.15% |
| 2018 Q3 | 12.61 Million USD | -38.88% |
| 2018 FY | 12.17 Million USD | -16.19% |
| 2018 Q4 | 12.17 Million USD | -3.49% |
| 2018 Q2 | 20.64 Million USD | 0.0% |
| 2018 Q1 | - USD | -100.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 FY | 14.53 Million USD | 0.0% |
| 2017 Q4 | 14.53 Million USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2016 Q3 | 81.49 Million USD | -71.76% |
| 2016 Q4 | - USD | -100.0% |
| 2016 Q1 | 361.15 Million USD | -5.32% |
| 2016 Q2 | 288.55 Million USD | -20.1% |
| 2016 FY | - USD | -100.0% |
| 2015 Q3 | 377.43 Million USD | 1.67% |
| 2015 Q4 | 381.43 Million USD | 1.06% |
| 2015 Q1 | 364.35 Million USD | 38.86% |
| 2015 FY | 381.43 Million USD | 45.37% |
| 2015 Q2 | 371.22 Million USD | 1.89% |
| 2014 Q1 | 341.62 Million USD | 1.83% |
| 2014 FY | 262.39 Million USD | -21.78% |
| 2014 Q3 | 257.96 Million USD | 1.68% |
| 2014 Q4 | 262.39 Million USD | 1.72% |
| 2014 Q2 | 253.69 Million USD | -25.74% |
| 2013 Q3 | 329.46 Million USD | 1.81% |
| 2013 Q2 | 323.59 Million USD | 1.76% |
| 2013 Q1 | 317.99 Million USD | -1.42% |
| 2013 FY | 335.47 Million USD | 4.0% |
| 2013 Q4 | 335.47 Million USD | 1.82% |
| 2012 FY | 322.56 Million USD | 82.61% |
| 2012 Q1 | 168.04 Million USD | -4.87% |
| 2012 Q2 | 169.54 Million USD | 0.89% |
| 2012 Q3 | 322.12 Million USD | 90.0% |
| 2012 Q4 | 322.56 Million USD | 0.14% |
| 2011 FY | 176.64 Million USD | 3.48% |
| 2011 Q4 | 176.64 Million USD | 0.89% |
| 2011 Q3 | 175.08 Million USD | 0.7% |
| 2011 Q2 | 173.86 Million USD | 1.64% |
| 2011 Q1 | 171.06 Million USD | 0.21% |
| 2010 FY | 170.71 Million USD | 322.94% |
| 2010 Q3 | 197.85 Million USD | -0.23% |
| 2010 Q1 | 38.4 Million USD | -4.86% |
| 2010 Q4 | 170.71 Million USD | -13.72% |
| 2010 Q2 | 198.32 Million USD | 416.44% |
| 2009 Q4 | 40.36 Million USD | -39.69% |
| 2009 Q3 | 66.92 Million USD | -3.5% |
| 2009 FY | 40.36 Million USD | -45.98% |
| 2009 Q2 | 69.35 Million USD | -3.38% |
| 2009 Q1 | 71.78 Million USD | -3.93% |
| 2008 Q3 | 106.43 Million USD | -3.33% |
| 2008 Q4 | 74.71 Million USD | -29.8% |
| 2008 Q1 | 102.93 Million USD | -2.66% |
| 2008 FY | 74.71 Million USD | -29.34% |
| 2008 Q2 | 110.09 Million USD | 6.95% |
| 2007 Q4 | 105.74 Million USD | 5.92% |
| 2007 Q1 | 105.63 Million USD | -2.26% |
| 2007 Q3 | 99.84 Million USD | -2.8% |
| 2007 FY | 105.74 Million USD | -2.15% |
| 2007 Q2 | 102.71 Million USD | -2.76% |
| 2006 Q4 | 108.07 Million USD | 7.04% |
| 2006 FY | 108.07 Million USD | 1.14% |
| 2006 Q3 | 100.96 Million USD | -2.26% |
| 2006 Q2 | 103.3 Million USD | -2.78% |
| 2006 Q1 | 106.25 Million USD | -0.57% |
| 2005 Q1 | 133.64 Million USD | -2.09% |
| 2005 Q2 | 107.38 Million USD | -19.65% |
| 2005 Q4 | 106.85 Million USD | 2.09% |
| 2005 Q3 | 104.67 Million USD | -2.52% |
| 2005 FY | 106.85 Million USD | -21.71% |
| 2004 Q3 | 103.08 Million USD | 4.24% |
| 2004 Q4 | 136.49 Million USD | 32.41% |
| 2004 Q1 | 99.4 Million USD | -1.8% |
| 2004 FY | 136.49 Million USD | 34.84% |
| 2004 Q2 | 98.89 Million USD | -0.51% |
| 2003 Q4 | 101.22 Million USD | 46.07% |
| 2003 FY | 101.22 Million USD | 55.13% |
| 2003 Q1 | 64.65 Million USD | -0.92% |
| 2003 Q2 | 66.6 Million USD | 3.01% |
| 2003 Q3 | 69.3 Million USD | 4.05% |
| 2002 Q4 | 65.25 Million USD | 57.75% |
| 2002 FY | 65.25 Million USD | 56.12% |
| 2002 Q1 | 41.69 Million USD | -0.23% |
| 2002 Q2 | 41.6 Million USD | -0.23% |
| 2002 Q3 | 41.36 Million USD | -0.56% |
| 2001 Q1 | 6.76 Million USD | -15.16% |
| 2001 FY | 41.79 Million USD | 424.02% |
| 2001 Q3 | 40.7 Million USD | 2.01% |
| 2001 Q4 | 41.79 Million USD | 2.67% |
| 2001 Q2 | 39.9 Million USD | 489.71% |
| 2000 Q3 | 5.97 Million USD | -40.39% |
| 2000 Q2 | 10.02 Million USD | -4.32% |
| 2000 Q1 | 10.47 Million USD | 0.0% |
| 2000 Q4 | 7.97 Million USD | 33.53% |
| 2000 FY | 7.97 Million USD | -27.49% |
| 1999 FY | 11 Million USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -466.743% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -16783.911% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -863281.818% |
| Autolus Therapeutics plc | 47.91 Million USD | -296.427% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -27588.63% |
| Shattuck Labs, Inc. | 3.4 Million USD | -5476.747% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -750.775% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -5764.947% |
| Aptose Biosciences Inc. | 621 Thousand USD | -30486.795% |
| Precision BioSciences, Inc. | 7.72 Million USD | -2359.459% |
| Dyadic International, Inc. | 88.87 Thousand USD | -213632.418% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -611.401% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -137540.58% |
| Nektar Therapeutics | 112.62 Million USD | -68.652% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -1923.91% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -191762.626% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -3771.667% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -45.373% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -2243.541% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -260097.26% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| IGM Biosciences, Inc. | 34.67 Million USD | -447.831% |
| INmune Bio, Inc. | 397 Thousand USD | -47744.836% |
| Opthea Limited | 200.53 Million USD | 5.282% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -281.628% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -1176.077% |
| Verastem, Inc. | 40.08 Million USD | -373.841% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -4214.948% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -1789.238% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -2795.046% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -3200.504% |
| NextCure, Inc. | 5.94 Million USD | -3092.873% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -210658.51% |
| Organovo Holdings, Inc. | 888 Thousand USD | -21290.09% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Arvinas, Inc. | 800 Thousand USD | -23643.0% |
| Ovid Therapeutics Inc. | 30 Million USD | -533.147% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -905.261% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -675.788% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -150.917% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -633.176% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -449.67% |
| Senti Biosciences, Inc. | 33.53 Million USD | -466.355% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -71040.075% |
| PureTech Health plc | 18.25 Million USD | -940.789% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -130895.862% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -1597.292% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -142.495% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| ChromaDex Corporation | 2.57 Million USD | -7276.466% |
| Beam Therapeutics Inc. | 159.91 Million USD | -18.781% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -166.79% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -721.379% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -104.168% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 40.14 Million USD | -373.157% |
| Mesoblast Limited | 100.48 Million USD | -89.031% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | 0.517% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -95.094% |
| MediWound Ltd. | 6.35 Million USD | -2891.244% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -88.815% |
| Fortress Biotech, Inc. | 60.85 Million USD | -212.12% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | 44.539% |
| Achilles Therapeutics plc | 1.07 Million USD | -17552.788% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -87.056% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -2260.432% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -233.856% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -2611.162% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -536.99% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 70.545% |
| FibroGen, Inc. | 89.69 Million USD | -111.762% |
| Celcuity Inc. | 37.03 Million USD | -412.871% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -4279.617% |
| ContextLogic Inc. | 6 Million USD | -3065.733% |
| GH Research PLC | 631 Thousand USD | -30002.06% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -4897.211% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -513262.162% |
| ImmuCell Corporation | 10.54 Million USD | -1702.04% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -9493.131% |
| Amarin Corporation plc | 8.73 Million USD | -2074.019% |
| TG Therapeutics, Inc. | 100.11 Million USD | -89.72% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -3419.437% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -10371.003% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -419.612% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -36639.652% |
| Aptorum Group Limited | 3.05 Million USD | -6110.365% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -521.26% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | 76.587% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -60008.861% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -81.577% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -495953.903% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -4160.745% |
| Ardelyx, Inc. | 51.54 Million USD | -268.487% |
| Ainos, Inc. | 5.92 Million USD | -3107.67% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -785.644% |
| Prothena Corporation plc | 10.72 Million USD | -1671.7% |
| HilleVax, Inc. | 25.24 Million USD | -652.432% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -856.849% |
| Celularity Inc. | 26.17 Million USD | -625.614% |
| Rallybio Corporation | 173 Thousand USD | -109694.22% |
| Cue Biopharma, Inc. | 4.2 Million USD | -4420.324% |
| Omeros Corporation | 329.7 Million USD | 42.39% |
| Humacyte, Inc. | 38.6 Million USD | -392.083% |
| Immunocore Holdings plc | 82.64 Million USD | -129.834% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -11675.821% |
| Blueprint Medicines Corporation | 610.96 Million USD | 68.911% |
| IO Biotech, Inc. | 1.83 Million USD | -10228.657% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -12927.709% |
| Summit Therapeutics Inc. | 103.29 Million USD | -83.894% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -99.544% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -290.157% |
| Pulmatrix, Inc. | 8.32 Million USD | -2181.062% |
| Elicio Therapeutics, Inc. | 6 Million USD | -3062.044% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -248.074% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -1367.316% |
| Acelyrin, Inc. | 1.19 Million USD | -15808.208% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -96.331% |
| Cytokinetics, Incorporated | 607.37 Million USD | 68.727% |
| Vor Biopharma Inc. | 31.83 Million USD | -496.745% |
| Evogene Ltd. | 10.65 Million USD | -1683.009% |
| Replimune Group, Inc. | 71.99 Million USD | -163.848% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -24925.56% |
| PDS Biotechnology Corporation | 19.5 Million USD | -873.763% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -721407.255% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 89.057% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| BioLineRx Ltd. | 6.62 Million USD | -2765.782% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -164.764% |
| Atai Life Sciences N.V. | 15.21 Million USD | -1148.728% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -74387.843% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -11998.344% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -340.195% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -46153.348% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -13774.653% |
| MiMedx Group, Inc. | 48.09 Million USD | -294.902% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -28544.893% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -6.668% |
| PTC Therapeutics, Inc. | 284.21 Million USD | 33.168% |
| Mereo BioPharma Group plc | 5.3 Million USD | -3483.849% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -32203.401% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -736.942% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Allakos Inc. | 38.21 Million USD | -397.04% |
| scPharmaceuticals Inc. | 38.81 Million USD | -389.408% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -2101.228% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Precigen, Inc. | 5.89 Million USD | -3122.12% |
| XOMA Corporation | 118.51 Million USD | -60.266% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -1786.424% |
| Incyte Corporation | 29.16 Million USD | -551.341% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -412.268% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -2304.659% |
| Seer, Inc. | 25.96 Million USD | -631.567% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 223 Million USD | 14.826% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -660.872% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -1266193.333% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -68178.515% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Novavax, Inc. | 168.01 Million USD | -13.051% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -139387.27% |
| UroGen Pharma Ltd. | 98.55 Million USD | -92.737% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -27.382% |
| Entera Bio Ltd. | 256 Thousand USD | -74096.875% |
| Lisata Therapeutics, Inc. | 137.00 USD | -138645155.474% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -3879.552% |
| Chimerix, Inc. | 125 Thousand USD | -151855.2% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -29486.293% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -37.338% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 96.281% |
| AnaptysBio, Inc. | 16.03 Million USD | -1084.411% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Portage Biotech Inc. | 7000.00 USD | -2713385.714% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -13192.092% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -1427.618% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -283801.054% |
| AbCellera Biologics Inc. | 71.22 Million USD | -166.693% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -10150.621% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| Daré Bioscience, Inc. | 3.91 Million USD | -4753.34% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | 40.08 Million USD | -373.912% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -135.736% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -266.058% |
| bluebird bio, Inc. | 224.41 Million USD | 15.362% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | 67.974% |
| DBV Technologies S.A. | 4.52 Million USD | -4096.73% |
| Fortress Biotech, Inc. | 60.85 Million USD | -212.12% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -2957.203% |
| CorMedix Inc. | 517.01 Thousand USD | -36638.728% |
| Travere Therapeutics, Inc. | 377.26 Million USD | 49.652% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -4939.639% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -18199.037% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -10962.551% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -20368.103% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -2061.156% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -987.445% |
| Onconetix, Inc. | 118.85 Thousand USD | -159708.846% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 4.35 Million USD | -4259.513% |
| Adagene Inc. | 13.54 Million USD | -1302.833% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | 8.225% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -284060.134% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | 63.381% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -193.508% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -1011.239% |
| SciSparc Ltd. | 24 Thousand USD | -791333.333% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -131.592% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -4865.856% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -1214.05% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | 5.875% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 91.893% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -825743.478% |
| 2seventy bio, Inc. | 244.01 Million USD | 22.158% |
| ADMA Biologics, Inc. | 130.59 Million USD | -45.446% |
| Clene Inc. | 7.15 Million USD | -2555.817% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -5525.872% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | 23.291% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -17151.953% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -72159.144% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | 1.389% |
| Absci Corporation | 4.66 Million USD | -3976.052% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 92.973% |
| Surrozen, Inc. | 882 Thousand USD | -21435.601% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -633.148% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -724.947% |
| Cingulate Inc. | 135.09 Thousand USD | -140496.155% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Jaguar Health, Inc. | 30.99 Million USD | -512.861% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -297.372% |
| Kronos Bio, Inc. | 25.37 Million USD | -648.43% |
| Innoviva, Inc. | 446.23 Million USD | 57.434% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -989.316% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -214.889% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -18688.961% |
| AlloVir, Inc. | 16.64 Million USD | -1040.942% |
| Century Therapeutics, Inc. | 46.65 Million USD | -307.098% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -2545724.956% |
| Kura Oncology, Inc. | 9.33 Million USD | -1935.405% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -2704.429% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -41192.174% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -9.318% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -4585.047% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -129158.45% |
| HCW Biologics Inc. | 6.3 Million USD | -2912.919% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -188.857% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -315.696% |
| Coherus BioSciences, Inc. | 473.36 Million USD | 59.874% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -308772.122% |
| Histogen Inc. | 4.38 Million USD | -4232.664% |
| Surrozen, Inc. | 882 Thousand USD | -21435.601% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Kodiak Sciences Inc. | 100 Million USD | -89.944% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -7497.79% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -203912.717% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -193.908% |
| Avalo Therapeutics, Inc. | 2 Million USD | -9397.2% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | 86.436% |
| Turnstone Biologics Corp. | 1.18 Million USD | -15875.105% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -174160.55% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -131.614% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -342.997% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -647.693% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Alkermes plc | 287.73 Million USD | 33.985% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -10371.003% |
| Arcellx, Inc. | 50.84 Million USD | -273.604% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -23.667% |
| Insmed Incorporated | 1.19 Billion USD | 84.083% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -12927.709% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -794.359% |
| Moolec Science SA | 99.04 Thousand USD | -191673.519% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -587.68% |
| Geron Corporation | 35.05 Million USD | -441.908% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -32039.425% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -343.028% |
| Royalty Pharma plc | 6.13 Billion USD | 96.904% |
| OmniAb, Inc. | 22.07 Million USD | -760.448% |
| Alector, Inc. | 30.45 Million USD | -523.667% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -11467.844% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -720.563% |
| Humacyte, Inc. | 38.6 Million USD | -392.083% |
| Structure Therapeutics Inc. | 4.01 Million USD | -4633.217% |
| Revance Therapeutics, Inc. | 426.59 Million USD | 55.474% |
| 89bio, Inc. | 24.79 Million USD | -666.058% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Aura Biosciences, Inc. | 16.87 Million USD | -1025.928% |
| Immunic, Inc. | 639 Thousand USD | -29625.196% |
| Veracyte, Inc. | 7.52 Million USD | -2424.173% |
| Genelux Corporation | 1.86 Million USD | -10079.207% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -18305.426% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -145047.215% |
| Immunovant, Inc. | - USD | -Infinity% |
| Vericel Corporation | 81.85 Million USD | -132.047% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 88.364% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -3057.839% |
| XBiotech Inc. | - USD | -Infinity% |
| Agenus Inc. | 137.32 Million USD | -38.318% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -317415.295% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -319.896% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -323.963% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -139564.706% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -42198.793% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -2932.312% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -15649.917% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -38664.082% |
| United Therapeutics Corporation | 300 Million USD | 36.685% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | -14.352% |
| XOMA Corporation | 118.51 Million USD | -60.266% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 117.62 Million USD | -61.479% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -3285.811% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -845.042% |
| uniQure N.V. | 130.06 Million USD | -46.038% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -2232.891% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -126317.794% |
| Windtree Therapeutics, Inc. | 15 Million USD | -1166.293% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -224.192% |
| Pluri Inc. | 29.05 Million USD | -553.784% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| MeiraGTx Holdings plc | 72.11 Million USD | -163.376% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -5210.148% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -108.957% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | 51.027% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -3285.811% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -40399.787% |
| Nutriband Inc. | 79.82 Thousand USD | -237847.536% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -4136.039% |
| Compugen Ltd. | 719 Thousand USD | -26317.803% |
| Roivant Sciences Ltd. | 477.85 Million USD | 60.251% |
| ProKidney Corp. | 3.61 Million USD | -5161.607% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -289939.549% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -415.62% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -22448.253% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -3649.388% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Biomea Fusion, Inc. | 7.83 Million USD | -2325.849% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -8734.605% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -1548.533% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -1798.491% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -124.64% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -1550.969% |
| Imunon, Inc. | 1.13 Million USD | -16572.094% |
| BioAtla, Inc. | 836 Thousand USD | -22620.574% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -115.0% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -3933.638% |
| Zura Bio Limited | - USD | -Infinity% |
| aTyr Pharma, Inc. | 13.76 Million USD | -1279.705% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -64.482% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -840.084% |
| Galecto, Inc. | 66 Thousand USD | -287693.939% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -1214.05% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 87.331% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -90.883% |
| PolyPid Ltd. | 6.37 Million USD | -2877.645% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -107.793% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Xencor, Inc. | 14.64 Million USD | -1197.254% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -126529.333% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -139387.27% |
| Instil Bio, Inc. | 81.42 Million USD | -133.269% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -28544.893% |
| OncoCyte Corporation | 2.2 Million USD | -8518.149% |
| Elevation Oncology, Inc. | 30.13 Million USD | -530.268% |
| Purple Biotech Ltd. | 163 Thousand USD | -116430.061% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -7392.86% |
| MacroGenics, Inc. | 30.19 Million USD | -529.037% |
| Verona Pharma plc | 48.37 Million USD | -292.657% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -20258.414% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -1961.024% |
| Aditxt, Inc. | 1.04 Million USD | -18133.27% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -620.905% |
| Curis, Inc. | 1.48 Million USD | -12656.481% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -27123.723% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -3165633.333% |
| BeiGene, Ltd. | 197.61 Million USD | 3.883% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -14074.925% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -223363.529% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -4942.315% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -260.713% |
| Adicet Bio, Inc. | 17.7 Million USD | -972.948% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -1282.718% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Generation Bio Co. | 89.77 Million USD | -111.58% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -756.182% |
| Invivyd, Inc. | 722 Thousand USD | -26208.033% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -291.621% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -6496532.726% |
| Moolec Science SA | 99.04 Thousand USD | -191673.519% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -352.377% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -1870.578% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -70.089% |
| Evaxion Biotech A/S | 8.48 Million USD | -2137.597% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -153.512% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -2955.727% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -706.933% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -105424.444% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -22702.401% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -5858.093% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -20193.162% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -1313.379% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -299.42% |
| ImmunityBio, Inc. | 836.95 Million USD | 77.305% |
| Korro Bio, Inc. | 31.21 Million USD | -508.483% |
| Kineta, Inc. | 150 Thousand USD | -126529.333% |
| BioVie Inc. | 349.89 Thousand USD | -54186.155% |
| Codexis, Inc. | 12.24 Million USD | -1451.45% |
| Celularity Inc. | 26.17 Million USD | -625.614% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -107611.588% |
| Cibus, Inc. | 17.67 Million USD | -974.709% |
| Annexon, Inc. | 29.19 Million USD | -550.716% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -16829.055% |
| Eyenovia, Inc. | 8.95 Million USD | -2020.566% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -189.289% |
| NeurAxis, Inc. | 27.07 Thousand USD | -701551.213% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -17904.171% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -35337.313% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -598299.597% |
| Notable Labs, Ltd. | 1.52 Million USD | -12347.182% |
| IN8bio, Inc. | 3.37 Million USD | -5521.308% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -59819.243% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -280.825% |
| Lumos Pharma, Inc. | 6 Million USD | -3065.733% |
| Liquidia Corporation | 2.36 Million USD | -7934.856% |
| Mustang Bio, Inc. | 1.97 Million USD | -9502.831% |
| Quantum-Si incorporated | 13.73 Million USD | -1282.718% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -2631.828% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -1961.024% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -513262.162% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -952668.86% |
| Vaxcyte, Inc. | 22.11 Million USD | -759.048% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -1877.759% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -1812.83% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -1034.507% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -146010.769% |
| PepGen Inc. | 17.1 Million USD | -1010.784% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -39972.574% |
| Solid Biosciences Inc. | 23.94 Million USD | -693.384% |
| Palisade Bio, Inc. | 90 Thousand USD | -210948.889% |
| Nutriband Inc. | 79.82 Thousand USD | -237847.536% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -4462.833% |
| Belite Bio, Inc | 578 Thousand USD | -32762.284% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -1461007.692% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -97809.278% |
| Altimmune, Inc. | 175 Thousand USD | -108439.429% |
| Peak Bio, Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -4279.617% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -13614.368% |
| Neurogene Inc. | 13.37 Million USD | -1320.354% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | 38.012% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -623.238% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| argenx SE | 15.35 Million USD | -1137.098% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -1812.83% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -112961.905% |
| Immunome, Inc. | 1.34 Million USD | -14074.925% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Design Therapeutics, Inc. | 2.33 Million USD | -8038.132% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -18894.4% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -368.905% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -1621.745% |
| Athira Pharma, Inc. | 1.21 Million USD | -15507.56% |
| XOMA Corporation | 118.51 Million USD | -60.266% |
| Merus N.V. | 10.48 Million USD | -1711.06% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -1314.431% |
| Rezolute, Inc. | 1.66 Million USD | -11342.41% |
| Clene Inc. | 7.15 Million USD | -2555.817% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -258862.753% |
| BeyondSpring Inc. | 3.36 Million USD | -5546.373% |
| Synlogic, Inc. | 12.49 Million USD | -1420.647% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -481.651% |
| Krystal Biotech, Inc. | 6.62 Million USD | -2769.245% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -11.131% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -3067.845% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -400871.058% |
| MannKind Corporation | 252.15 Million USD | 24.671% |
| Ikena Oncology, Inc. | 7.18 Million USD | -2545.46% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -95349.246% |
| Gossamer Bio, Inc. | 197.4 Million USD | 3.78% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -36427.692% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | 32.483% |
| Mural Oncology plc | 8.91 Million USD | -2031.568% |
| Disc Medicine, Inc. | 1.43 Million USD | -13127.298% |
| Champions Oncology, Inc. | 6.09 Million USD | -3017.413% |
| REGENXBIO Inc. | 82.22 Million USD | -131.014% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -38349.969% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -4183.807% |
| Vaxart, Inc. | 2.62 Million USD | -7141.479% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -69827.217% |
| Cellectis S.A. | 36.24 Million USD | -424.114% |
| Longeveron Inc. | 1.44 Million USD | -13017.68% |
| Repare Therapeutics Inc. | 1.01 Million USD | -18706.337% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | 83.228% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -324.276% |
| Revolution Medicines, Inc. | 80.57 Million USD | -135.736% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -5820.948% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -107212.994% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -154326.016% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | 73.79% |
| Denali Therapeutics Inc. | 44.98 Million USD | -322.276% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -1419.036% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -140496.155% |
| Passage Bio, Inc. | 22.92 Million USD | -728.69% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -3045.289% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -29257.651% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -841.949% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -46516.944% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -15888.552% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -40660.515% |
| OmniAb, Inc. | 22.07 Million USD | -760.448% |
| Anew Medical, Inc. | 1.54 Million USD | -12234.026% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -542.571% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -2002.779% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -510.949% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -4585.047% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -268.416% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -2883.257% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -1244.356% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -28165.476% |
| Alumis Inc. Common Stock | 30.86 Million USD | -515.502% |
| Equillium, Inc. | 384 Thousand USD | -49364.583% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -2984.007% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Dominari Holdings Inc. | 3.02 Million USD | -6172.919% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -960523.072% |
| vTv Therapeutics Inc. | 169 Thousand USD | -112292.899% |
| Bio-Techne Corporation | 319 Million USD | 40.456% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -233.305% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -6.372% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -1132.842% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -1433.909% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -3851.404% |
| Nkarta, Inc. | 82.27 Million USD | -130.879% |
| BioCardia, Inc. | 982 Thousand USD | -19242.566% |
| Iterum Therapeutics plc | 18.95 Million USD | -902.026% |